Logo image of ARQT

ARCUTIS BIOTHERAPEUTICS INC (ARQT) Stock Analyst Ratings

NASDAQ:ARQT - Nasdaq - US03969K1088 - Common Stock - Currency: USD

13.02  -0.4 (-2.98%)

Premarket: 13.29 +0.27 (+2.07%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to ARQT. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 19.89. This target is 52.76% above the current price.
ARQT was analyzed by 14 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ARQT.
In the previous month the buy percentage consensus was at a similar level.
ARQT was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
ARQT Historical Analyst RatingsARQT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -59 -53 -47 -41 -35 -29 -23 -17 -11 -5 5 10

Price Target & Forecast

Price Low Median Mean High 13.0213.1319.8919.8930.45 - 0.84% 52.76% 52.76% 133.87%
ARQT Current Analyst RatingARQT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6
Up and Down Grades
Date Firm Action Rating
2025-02-10 Guggenheim Reiterate Buy -> Buy
2025-01-13 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-07 Mizuho Maintains Outperform -> Outperform
2024-12-30 HC Wainwright & Co. Initiate Buy
2024-11-07 Needham Reiterate Buy -> Buy
2024-08-28 Jefferies Initiate Buy
2024-08-15 Needham Reiterate Buy -> Buy
2024-07-30 Needham Reiterate Buy -> Buy
2024-07-10 Needham Reiterate Buy -> Buy
2024-05-15 Mizuho Maintains Buy -> Buy
2024-05-15 Needham Maintains Buy -> Buy
2024-04-12 Needham Reiterate Buy -> Buy
2024-02-28 Mizuho Reiterate Buy -> Buy
2024-02-28 Needham Maintains Buy -> Buy
2024-02-28 Goldman Sachs Maintains Neutral -> Neutral
2024-02-23 Mizuho Reiterate Buy -> Buy
2024-01-03 Mizuho Upgrade Neutral -> Buy
2024-01-02 Mizuho Upgrade Neutral -> Buy
2023-11-13 Morgan Stanley Maintains Overweight -> Overweight
2023-11-08 JonesTrading Downgrade Buy -> Hold
2023-11-06 Needham Maintains Buy -> Buy
2023-11-06 HC Wainwright & Co. Maintains Buy -> Buy
2023-10-27 Mizuho Downgrade Buy -> Neutral
2023-10-13 Goldman Sachs Downgrade Buy -> Neutral
2023-09-25 Mizuho Reiterate Buy -> Buy
2023-08-22 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-08-10 Needham Reiterate Buy -> Buy
2023-08-09 TD Cowen Maintains Outperform -> Outperform
2023-07-18 Needham Reiterate Buy -> Buy
2023-06-28 Cantor Fitzgerald Reiterate Overweight -> Overweight